Home > Insider Trading > Filing (0000921895-23-000097)

Filing Details

Accession Number:: 0000921895-23-000097
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-11 17:11:40
Reporting Period:: 2023-01-09

Accepted Time:: 2023-01-11 17:11:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642375	Guardion Health Sciences Inc.	GHSI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380585	Louis Bradley Radoff	2727 Kirby Drive Unit 29L Houston TX 77098		No	No	Yes	No
1496916	Foundation Family Radoff	2727 Kirby Drive Unit 29L Houston TX 77098		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-01-09	63,983	$6.78	165,162	No	4	P	Direct
Common Stock	Acquisiton	2023-01-09	20,838	$7.19	186,000	No	4	P	Direct
Common Stock	Acquisiton	2023-01-10	18,630	$7.31	204,630	No	4	P	Direct
Common Stock	Acquisiton	2023-01-10	13,270	$8.00	217,900	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,100	Indirect	By The Radoff Family Foundation

Footnotes

This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7762 to $7.0417 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.48 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.70 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.97 to $8.00 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.